Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency

CONCLUSIONS: This study extends knowledge of the somapacitan dose-IGF-I response and provides information on clinical dosing of once-weekly somapacitan in patients with AGHD.PMID:35521713 | DOI:10.1530/EJE-21-1167

Source: European Journal of Endocrinology - May 6, 2022 Category: Endocrinology Authors: Rasmus Juul Kildemoes Christian Hollensen Beverly M K Biller Gudmundur Johannsson Yutaka Takahashi Michael H øjby Rasmussen Source Type: research